BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 15222464)

  • 1. The antimicrobial activity of lactoferrin: current status and perspectives.
    Orsi N
    Biometals; 2004 Jun; 17(3):189-96. PubMed ID: 15222464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.
    Zarzosa-Moreno D; Avalos-Gómez C; Ramírez-Texcalco LS; Torres-López E; Ramírez-Mondragón R; Hernández-Ramírez JO; Serrano-Luna J; de la Garza M
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33302377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activities of lactoferrin.
    van der Strate BW; Beljaars L; Molema G; Harmsen MC; Meijer DK
    Antiviral Res; 2001 Dec; 52(3):225-39. PubMed ID: 11675140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of lactoferrin in the iron metabolism. Part II. Antimicrobial and antiinflammatory effect of lactoferrin by chelation of iron].
    Artym J
    Postepy Hig Med Dosw (Online); 2010 Nov; 64():604-16. PubMed ID: 21160095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential lactoferrin activity against pathogenic viruses.
    Redwan EM; Uversky VN; El-Fakharany EM; Al-Mehdar H
    C R Biol; 2014 Oct; 337(10):581-95. PubMed ID: 25282173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection.
    Yen CC; Shen CJ; Hsu WH; Chang YH; Lin HT; Chen HL; Chen CM
    Biometals; 2011 Aug; 24(4):585-94. PubMed ID: 21327478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin: a multifunctional glycoprotein.
    Vorland LH
    APMIS; 1999 Nov; 107(11):971-81. PubMed ID: 10598868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral properties of lactoferrin--a natural immunity molecule.
    Berlutti F; Pantanella F; Natalizi T; Frioni A; Paesano R; Polimeni A; Valenti P
    Molecules; 2011 Aug; 16(8):6992-7018. PubMed ID: 21847071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.
    Andersen JH; Jenssen H; Sandvik K; Gutteberg TJ
    J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of lactoferrin towards naked viruses.
    Seganti L; Di Biase AM; Marchetti M; Pietrantoni A; Tinari A; Superti F
    Biometals; 2004 Jun; 17(3):295-9. PubMed ID: 15222481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin functions: current status and perspectives.
    Valenti P; Berlutti F; Conte MP; Longhi C; Seganti L
    J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S127-9. PubMed ID: 15220678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactoferrin and Peptide-derivatives: Antimicrobial Agents with Potential Use in Nonspecific Immunity Modulation.
    Drago-Serrano ME; Campos-Rodriguez R; Carrero JC; de la Garza M
    Curr Pharm Des; 2018; 24(10):1067-1078. PubMed ID: 29589540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.
    Han FF; Gao YH; Luan C; Xie YG; Liu YF; Wang YZ
    J Dairy Sci; 2013 Jun; 96(6):3471-87. PubMed ID: 23567049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin structure and functions.
    Legrand D; Pierce A; Elass E; Carpentier M; Mariller C; Mazurier J
    Adv Exp Med Biol; 2008; 606():163-94. PubMed ID: 18183929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects of the use of lactoferrin in dentistry.
    Krupińska AM; Bogucki Z
    J Oral Biosci; 2021 Jun; 63(2):129-133. PubMed ID: 33662566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii.
    Anand N; Sehgal R; Kanwar RK; Dubey ML; Vasishta RK; Kanwar JR
    Int J Nanomedicine; 2015; 10():6355-69. PubMed ID: 26504384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts.
    Andersen JH; Osbakk SA; Vorland LH; Traavik T; Gutteberg TJ
    Antiviral Res; 2001 Aug; 51(2):141-9. PubMed ID: 11431038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactoferrin a multiple bioactive protein: an overview.
    García-Montoya IA; Cendón TS; Arévalo-Gallegos S; Rascón-Cruz Q
    Biochim Biophys Acta; 2012 Mar; 1820(3):226-36. PubMed ID: 21726601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
    Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
    Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection.
    Rosa L; Cutone A; Conte MP; Campione E; Bianchi L; Valenti P
    Biometals; 2023 Jun; 36(3):417-436. PubMed ID: 35920949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.